Eisai
4523.T
#1534
Rank
A$17.23 B
Marketcap
$60.92
Share price
0.52%
Change (1 day)
-34.48%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.26

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.27. In 2022 the company made an earnings per share (EPS) of $2.40 a decrease over its 2021 EPS that were of $10.67.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.2635.74%
2022$2.40-77.48%
2021$10.67-41.88%
2020$18.36-0.94%
2019$18.5352.59%
2018$12.15124.17%
2017$5.42-49.42%
2016$10.7137.08%
2015$7.82-11.75%
2014$8.86-3.23%
2013$9.15-18.56%
2012$11.24-15.51%
2011$13.30-3.75%
2010$13.82-1.36%
2009$14.01